NCT02044276 / 2013-001284-23: A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced Neutropenia |
|
|
| Completed | 3 | 101 | Europe | lipegfilgrastim, XM22, pegfilgrastim, Neulasta® | Teva Branded Pharmaceutical Products R&D, Inc. | Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia | 08/17 | 04/18 | | |
